Literature DB >> 2437194

Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus.

A L Smith, K Bottomly, D F Winograd.   

Abstract

Mouse hepatitis virus and Sendai virus are among the most common viruses naturally infecting laboratory mice. Concanavalin A-stimulated in vitro proliferative responses of splenocytes were examined after infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus (MHV-JHM) or Sendai virus. Mice were exposed to these viruses by presumed natural routes (per os or intranasally). Immunodepression was marked but transient among BALB/cByJ mice exposed to MHV-JHM. Among mice exposed to Sendai virus and examined over a 21-day period, spleen cells from only one mouse, sacrificed 10 days postinoculation, exhibited a severely impaired ability to respond to concanavalin A. Lymphokine production by spleen cells from control and infected mice was then assessed. IL 2 was either absent or present at very low levels in culture supernates of concanavalin A-unresponsive spleen cells from MHV-JHM-infected mice. Spleen cells from the single Sendai virus-infected mouse also produced very low levels of IL 2. In contrast, IL 1 was detected in supernatants of all spleen cell cultures derived from control, MHV-JHM-infected, or Sendai virus-infected mice. There was not a clear correlation between concanavalin A responsiveness and the ability of spleen cells to produce interferon-gamma. These results stress the importance of using laboratory mice of known microbiological status for immunologic experiments.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2437194

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Mouse hepatitis virus infection suppresses modulation of mouse spleen T-cell activation.

Authors:  J M Cook-Mills; H G Munshi; R L Perlman; D A Chambers
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Spontaneous production of interleukin-2 and interleukin-3 by spleen cells from mice infected with mouse hepatitis virus type 4.

Authors:  S Kyuwa; K Yamaguchi; M Hayami; J Hilgers; K Fujiwara
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

3.  Immunoregulatory activity of peptides related to platelet factor 4.

Authors:  M B Zucker; I R Katz; G J Thorbecke; D C Milot; J Holt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Specific T-cell response correlates with resistance of genetic heterogeneous mouse populations to mouse hepatitis virus 3 infection.

Authors:  R C Vassão; W H Cabrera; O C Ibanez; C A Pereira
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Responses of mice to murine coronavirus immunization.

Authors:  A L Smith; M S de Souza; D Finzi; S W Barthold
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice.

Authors:  C Godfraind; K V Holmes; J P Coutelier
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59.

Authors:  O L Wijburg; M H Heemskerk; C J Boog; N Van Rooijen
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

8.  Effect of adoptive transfer of CD4, CD8 and B cells on recovery from MHV3-induced immunodeficiencies.

Authors:  L Lamontagne; P Jolicoeur; D Decarie; J Menezes
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

9.  Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi.

Authors:  A C Torrecilhas; E Faquim-Mauro; A V Da Silva; I A Abrahamsohn
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

10.  The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM.

Authors:  A L Smith; S W Barthold; M S de Souza; K Bottomly
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.